Surgical appliance and supplies manufacturing

Ended Awarded Last action

Contract number
HT009025FG0510018
Awardee
Awarding agency
Obligated
$17,624

Award facts

Contract value 100% obligated
$17,624.33 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
339113 Surgical Appliance and Supplies Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Mounds View, MN 55112, USA

Award details come from SAM.gov/FPDS.

About this award

On May 29, 2025, the Defense Health Agency awarded a $17,624.33 firm fixed-price blanket purchase agreement (BPA) call order to Harvard Bioscience Inc., operating through its Data Sciences International division, for surgical appliances and supplies manufacturing. This task order represents a call against Harvard Bioscience's existing $4.8 million single-award BPA with the Defense Health Agency, which was originally established on May 4, 2022, and extends through May 3, 2027. The contract carries an ultimate completion date of September 30, 2025, with performance occurring at the company's Mounds View, Minnesota facility. No small business set-aside was applied to this award.

Harvard Bioscience, a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, specializes in advanced physiological monitoring technologies and biomedical research equipment, including wireless implantable telemetry transmitters, respiratory monitoring systems, and data acquisition software. The company's existing BPA with the Defense Health Agency encompasses a broad range of specialized biomedical solutions, including telemetry devices, pre-implanted research animals, hardware and software systems, surgical supplies, and technical support services. Task orders issued under this BPA have generated over $1.5 million in cumulative procurement value since inception, with the Defense Health Agency and Army Medical Command serving as the primary issuing entities, underscoring the strategic importance of Harvard Bioscience's capabilities to military health and defense research programs.

Quick answers

Who was awarded contract HT009025FG0510018?

HT009025FG0510018 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on May 29, 2025.

How much is contract HT009025FG0510018 worth?

The government has obligated $17,624 on HT009025FG0510018.

Is contract HT009025FG0510018 an order under another contract?

Yes. HT009025FG0510018 is a BPA call under W81XWH22A0001, a blanket purchase agreement.

Was contract HT009025FG0510018 competed?

The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award